HELOCYTE Trademark

Trademark Overview

On Wednesday, July 1, 2015, a trademark application was filed for HELOCYTE with the United States Patent and Trademark Office. The USPTO has given the HELOCYTE trademark a serial number of 86680734. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, December 8, 2025. This trademark is owned by Helocyte, Inc.. The HELOCYTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines; pharmaceutical research and development; biotechnology research and development; biopharmaceutical research and development; provision of scientific research information in the field of pharmaceuticals and clinical trials
helocyte

General Information

Serial Number86680734
Word MarkHELOCYTE
Filing DateWednesday, July 1, 2015
Status800 - REGISTERED AND RENEWED
Status DateMonday, December 8, 2025
Registration Number5019023
Registration DateTuesday, August 9, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2015

Trademark Statements

Goods and ServicesDevelopment of pharmaceutical preparations and medicines; pharmaceutical research and development; biotechnology research and development; biopharmaceutical research and development; provision of scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 8, 2015
Primary Code042
First Use Anywhere DateTuesday, March 31, 2015
First Use In Commerce DateTuesday, March 31, 2015

Trademark Owner History

Party NameHelocyte, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBay Harbor Islands, FL 33154
Party NameHelocyte, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameHelocyte, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019

Trademark Events

Event DateEvent Description
Saturday, July 4, 2015NEW APPLICATION ENTERED
Wednesday, July 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 9, 2015ASSIGNED TO EXAMINER
Thursday, October 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 24, 2015PUBLISHED FOR OPPOSITION
Tuesday, November 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 26, 2016TEAS STATEMENT OF USE RECEIVED
Monday, June 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 26, 2016USE AMENDMENT FILED
Tuesday, June 21, 2016STATEMENT OF USE PROCESSING COMPLETE
Friday, July 1, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, July 2, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 9, 2016REGISTERED-PRINCIPAL REGISTER
Monday, August 9, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 26, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, August 9, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 21, 2025TEAS SECTION 8 & 9 RECEIVED
Wednesday, December 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 8, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, December 8, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, December 8, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

helocyte development research pharmaceutical field pharmaceuticals clinical trials information biopharmaceutical preparations